We previously developed a two-plasmid in vitro ligation method that did not require a recombination step to produce new recombinant E1-or E1/E3-deleted adenoviral vectors. In this study, we have modified the system to improve the simplicity of vector construction and, in addition, to allow for production of an E1/E4-deleted vector. 2013 
INTRODUCTION
O N E O F TH E PR O B LEM S with the use of adenovirus (Ad) vectors has been the difficulty in the construction of new vectors. Several different protocols have been developed using various technologies to increase the ease of construction (Bett et al., 1994; Ketner et al., 1994; Chartier et al., 1996 ; Crouzet et al., 1997; He et al., 1998) . We described an in vitro ligation method (Mizuguchi and Kay, 1998 ) that used two plasmids for constructing first-generation Ad vectors. The vector plasmid has a complete Ad genome with a deletion of the E1 (and E3) region and three unique restriction sites, I-CeuI, SwaI, and PISceI, in the E1 deletion region. I-CeuI and PI-SceI are intronencoded endonucleases (Marshall and Lemieux, 1991; Gimble and Thorner, 1992 ) that do not cut the Ad genome. The shuttle plasmid has a multicloning site between the I-CeuI and PISceI site. Both plasm ids have a pUC-derived replication origin and ampicillin resistance gene. After the gene of interest is inserted into the multicloning site of the shuttle plasmid, the gene can be easily introduced into E1 deletion site of the vector plasmid at the I-CeuI and PI-SceI site. SwaI digestion of the ligation products prevents the production of a plasmid containing a parental Ad genome (null vector). Recombinant virus can be produced by the transfection of the PacI-digested, linearized plasmid into 293 cells.
In this study, we improve on the system by using a shuttle plasmid that has a kanam ycin resistance gene instead of an ampicillin resistance gene. Thus, no fragm ent isolation from a gel was required with the new shuttle plasmid. In addition, a series of shuttle plasmids with different promoters, and a series of vector plasmids for producing E1-, E1/E3-, and E1/E3/E4-deleted vectors, were constructed. (Mizuguchi and Kay, 1998) . The construction of the plasmids is described in Materials and Methods. changed into PacI sites by using oligonucleotide 5 (59 -CGT-TAATTAA-39 ) (PacI recognition sequence is underlined). The resulting plasm ids were named pAdHM10 and pAdHM12, respectively (Fig. 1A) .
MATERIALS AND METHODS

Construction of recombinant plasmids
Shuttle plasmid pHM5 was constructed by ligation of the DraI/SspI fragment of pHM3 (Mizuguchi and Kay, 1998) with the NheI/BamHI fragment of pACYC177 (Nippon Gene, Toyama, Japan) after the NheI/BamHI sites were filled by the Klenow fragment of DNA polymerase (Fig. 1B) . pHMCMV5,-6 and pHMRSV5,-6 were constructed by using pHM5 and the cytomegalovirus (CMV) promoter and bovine growth hormone (BGH) polyadenylation signal from pcDNA3.1/Zeo (Invitrogen, Carlsbad, CA) or the Rous sarcoma virus long terminal repeat (RSV LTR) enhancer/ promoter from pREP10 (Invitrogen), respectively (Fig. 1B) . Detailed information about the constructions is available from the authors on request.
Construction of E1/E3-or E1/E3/E4-deleted recombinant Ad vector DNA expressing b -galactosida se
Escherichia coli b -galactosidase (lacZ) gene derived from pCMVb (Clontech, Palo Alto, CA) was subcloned into the XhoI/NotI site of pcDNA3.1/Zeo, after the SmaI site of pCMVb was changed into a XhoI site by using a XhoI linker. The lacZ gene was then cloned by digestion with NotI and XbaI and inserted into the NotI/XbaI site of pHMCMV5, resulting in pHMCMVLacZ-1. pHMCMVLacZ-1, pAdHM10, and pAdHM12 were digested with I-CeuI and PI-SceI, and purified by phenol-chloroform extraction and ethanol precipitation. Digested pAdHM10 or pAdHM12 (0.
To prevent the production of a plasmid containing a parental Ad genom e, the ligation products were digested with SwaI, transform ed with chemical-com petent DH5a (electrocompete nt DH5a can also be used), and grown in ampicillin, resulting in pAdHM10-LacZ and pAdHM12-LacZ.
Generation of recombinant virus
pAdHM10-LacZ and pAdHM12-LacZ DNAs were digested with PacI and purified by phenol-chloroform extraction and ethanol precipitation. To make an E1/E3-or E1/E3/E4-deleted Ad vector, linearized pAdHM10-LacZ or pAdHM12-LacZ was transfected into 293 cells or VK10-9 cells, which are 293 cells transformed with constructs containing the E4 transcription unit and pIX-coding sequences under the control of the inducible metallothionein promoter (Krougliak and Graham, 1995) (kindly provided by V. Krougliak, Mouni Sinai Medical Center, New York, NY), respectively. E1/E3-deleted virus was prepared as described previously (Mizuguchi and Kay, 1998 ). In the case of E1/E3/E4-deleted Ad vector, the cells were cultured with Dulbecco's modified Eagle's medium (GIBCO, Grand Island, NY) containing 10% fetal calf serum and 10 2 6 M (final concentration) dexamethazone for 14 days. At this point, no cytopathic effect (CPE) was observed. The cell lysate prepared from the cells transfected by pAdHM12-LacZ was added to fresh VK10-9 cells. CPE was observed in about 7 days. Ad DNA was isolated from the cells with full cytopathic effect as described previously (Lieber et al., 1996) .
FIG. 2. Diagram of construction of E1/E3-or E1/E3/E4-deleted Ad vector expressing lacZ.
RESULTS AND DISCUSSION
The ampicillin resistance gene of the shuttle plasmid pHM3 (Mizuguchi and Kay, 1998) was exchanged with a kanamycin resistance gene, resulting in pHM5 (Fig. 1B) . This plasmid was used to derive shuttle plasmids that already have the CMV or RSV promoter and BGH polyadenylation signal in both orientations as shown in Fig. 1B. pAdHM10 and pAdHM12 were prepared for the construction of E1/E3-and E1/E3/E4-deleted vectors, respectively. pAdHM10 has a larger E3 deletion than pAdHM4 (pAdHM10, 3.1 kb; pAdHM4, 2.6 kb). Up to 4.9, 7.6, 8.1, and 10.9 kb of exogenous DNA can be introduced into pAdHM3, 2 4, 2 10, and 2 12, respectively (Fig. 1A) .
We constructed the CMV prom oter-driven lacZ-expressing E1/E3-and E1/E3/E4-deleted Ad vectors as a representative example. The steps are diagrammed in Fig. 2 . First, the lacZ gene was inserted into the multicloning site of pHMCMV5, resulting in pHMCMVLacZ-1. Second, pHMCMVLacZ-1 and vector plasmids (pAdHM 10 and pAdHM12) were digested with ICeuI and PI-SceI, and directly ligated without gel purification of either the lacZ expression cassette or the vector viral sequence. Third, the ligation products were digested with SwaI, transformed with DH5a , and selected with ampicillin. SwaI digestion cut parental vector plasmid, but not the expected recom binant plasmid. Only the ligated Ad plasmid DNAs with the lacZ expression cassette were selected. More than 75% of the transform ants (seven of nine clones) had the correct insert as determined by restriction digestion. Fourth, recombinant plasm id pAdHM10-LacZ or pAdHM12-LacZ was cleaved with PacI, and directly transfected into 293 cells or 293 cells expressing E4 gene product (VK10-9) (Krougliak and Graham , 1995) , resulting in a homogeneous population of recombinant E1/E3-or E1/E3/E4-deleted vector expressing lacZ (AdHM10-LacZ or AdHM12-LacZ), respectively. DNA restriction analysis showed that vector plasm id with or without the lacZ expression cassette and viral DNA (AdHM10-LacZ or AdHM12-LacZ) contained the expected fragments (Fig. 3) .
Finally, to confirm the functionality of the vector, HeLa cells were found to be equally transducible with either the AdHM10-LacZ vector or the AdHM12-LacZ vector as determined by XGal staining (data not shown).
Several systems for generating Ad vectors have been described; they include homologous recombination in mammalian cells (Bett et al., 1994) , yeast (Ketner et al., 1994) , or bacteria (Chartier et al., 1996; Crouzet et al., 1997; He et al., 1998) . The method we used to produce recombinant first-generation Ad vector requires molecular biology cloning techniques and no recom bination steps in eukaryotic and/or prokaryotic cells. Here we modified this system by deleting the time-consumi ng process of gel purification of cloned DNA fragments, and constructed plasmids with various precloned cDNA-inserta ble expression cassettes. Moreover, the system described herein includes a plasmid to produce E1/E3/E4-deleted vectors. These types of modifications allow any laboratory to construct adenoviral vectors easily for gene transfer studies.
